The study of BushenHuoxue Formula in clinical treatment evaluation for bone grafting after posterior lumbar interbody fusion.

Phase 1

Not yet recruiting

• Conditions: umbar spinal stenosis

• Registration Number: ITMCTR2200006667
• Lead Sponsor: Wangjing Hospital, China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-02-20

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. It meets the diagnostic criteria of lumbar spinal stenosis or Lumbar disc herniation in western medicine, and already took posterior lumbar interbody fusion;
2. TCM syndrome differentiation after the operation is kidney deficiency and blood stasis;
3. Adult patients aged 20 to 75 years;
4. Patients who voluntarily participated in the clinical trial and signed the informed consent.
Only those who meet the above four criteria can be selected as eligible subjects for this clinical study.

Exclusion Criteria

1. Patients with lumbar tuberculosis, lumbar tumor, or lumbar compression fracture;
2. Postoperative complications such as infection and organ failure;
3. Patients with past adverse reactions to traditional Chinese Medicine.
If any one of the above options is met, the case is excluded.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified